Analysed COYA THERAPEUTICS INC (COYA:NASDAQ) News Sources
Coya Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
11-08-2026
yahoo.com
Coya Therapeutics Announces Enrollment of 100th Participant in Phase 2/3 ALSTARS Trial of COYA 302 for the Treatment of ALS
15-09-2026
yahoo.com
Coya Therapeutics Announces Completion of Full Enrollment in Phase 2/3 ALSTARS Trial of COYA 302 for the Treatment of ALS
05-10-2026
yahoo.com
Coya Therapeutics secures FDA fast track status for COYA 302
14-05-2026
pharmaceutical-technology.com
Coya Therapeutics Announces the First Cohort of Patients in the ALSTARS Trial Have Begun the Blinded Active-Treatment Extension Phase
08-06-2026
yahoo.com
Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease
15-06-2026
yahoo.com
Coya Therapeutics Announces Publication of Preclinical Study Demonstrating Combination Immunomodulatory Effects of COYA 303 in a Well-Established Model of Peripheral and CNS Inflammation
08-09-2026
yahoo.com
Coya Therapeutics Announces Participation at Chardan's 10th Annual Healthcare Conference
13-10-2026
yahoo.com
What is the current price of COYA THERAPEUTICS INC (COYA:NASDAQ)?
The current price of COYA THERAPEUTICS INC (COYA:NASDAQ) is $4.34.
COYA THERAPEUTICS INC (COYA:NASDAQ) absolute price change since previous trading day?
The absolute price change of COYA THERAPEUTICS INC (COYA:NASDAQ) since the previous trading day is $0.16.
COYA THERAPEUTICS INC (COYA:NASDAQ) percentage price change since previous trading day?
The percentage price change of COYA THERAPEUTICS INC (COYA:NASDAQ) since the previous trading day is 3.8278%.
What is the most recent average sentiment score for COYA THERAPEUTICS INC (COYA:NASDAQ)?
The most recent average sentiment score for COYA THERAPEUTICS INC (COYA:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for COYA THERAPEUTICS INC (COYA:NASDAQ)?
The most recent sentiment for COYA THERAPEUTICS INC (COYA:NASDAQ) is .
SEC-8K** Filing Available For COYA THERAPEUTICS INC (COYA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.